VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000082 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
9,340
Total Value
$2,121,227.32
P&L
+inf% (+$2,252,748.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Technical Ops. Off. | Common Stock | โ | Feb 17, 2026 | Grant/Award | 4,962 | $0.00 | $0.00 | 25,105 | Direct | โ | View Details | |
EVP, Chief Technical Ops. Off. | Common Stock | โ | Feb 17, 2026 | Tax Withholding | 1,530 | $483.75 | $740,137.50 | 23,575 | Direct | โ | View Details | |
EVP, Chief Technical Ops. Off. | Common Stock | โ | Feb 17, 2026 | Sale | 2,031 | $489.46 | $994,093.26 | 21,544 | Direct | โ | View Details | |
EVP, Chief Technical Ops. Off. | Common Stock | โ | Feb 18, 2026 | Sale | 817 | $473.68 | $386,996.56 | 20,727 | Direct | โ | View Details |